We are live on ! Find out more
OFIX icon

Orthofix Medical

149 hedge funds and large institutions have $542M invested in Orthofix Medical in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 47 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

380% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 5

15% more capital invested

Capital invested by funds: $472M → $542M (+$70M)

15% more funds holding

Funds holding: 130149 (+19)

0% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 47

3.95% less ownership

Funds ownership: 94.77%90.82% (-3.9%)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

97% less call options, than puts

Call options by funds: $5K | Put options by funds: $199K

Holders
149
Holders Change
+19
Holders Change %
+14.62%
% of All Funds
2.14%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
24
Increased
47
Reduced
47
Closed
5
Calls
$5K
Puts
$199K
Net Calls
-$194K
Net Calls Change
+$92K
Name Holding Trade Value Shares
Change
Change in
Stake
TI
76
Trexquant Investment
Connecticut
$496K +$509K +31,768 New
Verition Fund Management
77
Verition Fund Management
Connecticut
$495K +$65.9K +4,112 +15%
Renaissance Technologies
78
Renaissance Technologies
New York
$481K -$405K -25,280 -45%
RC
79
RBF Capital
California
$469K
Two Sigma Investments
80
Two Sigma Investments
New York
$440K +$144 +9 +0%
II
81
Inspire Investing
Idaho
$417K +$428K +26,687 New
Citigroup
82
Citigroup
New York
$393K +$274K +17,117 +213%
Franklin Resources
83
Franklin Resources
California
$337K +$91.4K +5,702 +37%
MIM
84
MetLife Investment Management
New Jersey
$325K
AQR Capital Management
85
AQR Capital Management
Connecticut
$321K -$181K -11,284 -35%
TA
86
Teton Advisors
New York
$316K -$8.01K -500 -2%
GCP
87
GSA Capital Partners
United Kingdom
$312K +$320K +19,977 New
SAM
88
Shell Asset Management
Netherlands
$308K +$316K +19,716 New
Wells Fargo
89
Wells Fargo
California
$305K +$11.3K +706 +4%
Janus Henderson Group
90
Janus Henderson Group
United Kingdom
$299K
SPA
91
Sherbrooke Park Advisers
New York
$299K +$139K +8,675 +83%
HF
92
HRT Financial
New York
$296K +$304K +18,961 New
Mirae Asset Global ETFs Holdings
93
Mirae Asset Global ETFs Holdings
Hong Kong
$289K +$9.85K +615 +3%
CF
94
Corebridge Financial
Texas
$282K -$1.78K -111 -0.6%
PAS
95
Point72 Asia (Singapore)
Singapore
$270K +$277K +17,295 New
SG Americas Securities
96
SG Americas Securities
New York
$267K +$117K +7,278 +74%
Balyasny Asset Management
97
Balyasny Asset Management
Illinois
$252K +$97.6K +6,091 +61%
YIH
98
Y-Intercept (HK)
Hong Kong
$244K -$292K -18,225 -54%
A
99
AlphaQuest
New York
$217K +$145K +9,063 +187%
Assenagon Asset Management
100
Assenagon Asset Management
Luxembourg
$216K +$222K +13,860 New

OFIX Hedge Fund Activity: Q3 2024 in Review

149 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q3 2024, worth a combined $542M — up 15% from $472M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new OFIX positions and 5 closed out — a net gain of 19 holders — while 47 added to existing stakes and 47 trimmed.

The largest buyer was Juniper Investment Company, adding an estimated $8.93M. The largest seller was Glenview Capital Management, cutting an estimated $16.7M.

  • 149 institutional investors held Orthofix Medical (OFIX) as of Q3 2024, up from 130 in Q2 2024.
  • Funds reported $542M of Orthofix Medical stock for Q3 2024, up 15% quarter-over-quarter.
  • 24 funds opened new Orthofix Medical positions in Q3 2024 and 5 closed out, a net change of +19 holders.
  • The largest Orthofix Medical buyer in Q3 2024 was Juniper Investment Company, an estimated $8.93M added.
  • The largest Orthofix Medical seller in Q3 2024 was Glenview Capital Management, an estimated $16.7M sold.

Based on aggregated 13F filings for Q3 2024.